Want to see JP:4366 full AI Analyst Report?
Daito Chemix Corporation (4366) AI Stock Analysis
Daito Chemix Corporation
(TSE/TYO:4366)
Daito Chemix scores below average, driven primarily by weak financial performance: steady revenue growth has been offset by severe margin compression, a FY2024 net loss, rising leverage and a multi-year history of negative free cash flow. Technicals add to the caution, with the price below most key moving averages and a negative MACD indicating downward momentum. An inexpensive 12.4x P/E and a 1.79% dividend yield provide partial support, and the recent return to positive earnings and free cash flow in FY2025 suggests stabilization — but sustained margin recovery is needed before the profile improves.
Daito Chemix Corporation (4366) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 14.43B
- Dividend Yield
- 1.79%
- Average Volume (3M)
- 94.96K
- Price to Earnings (P/E)
- 12.4
- Beta (1Y)
- 1.30
- Revenue Growth
- 10.12%
- EPS Growth
- 43.23%
- Country
- Japan
- Employees
- 328
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
Daito Chemix Corporation Business Overview & Revenue Model
Company Description
Daito Chemix Corporation, together with its subsidiaries, manufactures and sells specialty and fine chemicals in Japan, South Korea, Singapore, rest of Asia, and the United States. It operates through Chemical Products Business and Environment-Relate...
How the Company Makes Money
Daito Chemix primarily makes money by selling specialty chemical products—especially organic pigments and pigment-related materials—to business customers (B2B). Its revenue model is largely product-sales driven: it manufactures pigments and color mat...
Daito Chemix Corporation Financial Statement Overview
Summary
Financials are below average. Revenue has grown steadily from ¥14.0B (FY2021) to ¥18.6B (FY2025) with ¥19.5B projected for FY2026, but margins have compressed sharply — gross margins fell from ~18% to ~11% and net margins from ~10% to ~4%. The FY2024 net loss of ¥1.0B was a significant setback. The balance sheet remains solid on an equity base of ¥16.4B, but total debt has more than doubled to ¥6.9B (D/E 0.42) while ROE declined from 11.1% to a projected 4.8%. Cash flow is volatile, with negative free cash flow in three of the last four years due to heavy capex, though FY2025 FCF turned positive at ¥1.9B. Stabilization is evident, but margin recovery and sustained cash generation remain unproven.
Income Statement
42NeutralBalance Sheet
50NeutralCash Flow
48Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.83B | 19.48B | 18.64B | 15.81B | 16.38B | 16.13B |
| Gross Profit | 2.33B | 2.22B | 2.07B | 1.90B | 2.44B | 2.93B |
| EBITDA | 2.30B | 2.42B | 2.38B | 839.00M | 2.08B | 2.36B |
| Net Income | 981.00M | 791.00M | 820.00M | -1.00B | 922.00M | 1.58B |
Balance Sheet | ||||||
| Total Assets | 29.57B | 28.80B | 24.78B | 25.12B | 24.90B | 22.47B |
| Cash, Cash Equivalents and Short-Term Investments | 5.41B | 4.85B | 2.77B | 2.25B | 2.39B | 3.42B |
| Total Debt | 6.92B | 6.92B | 5.45B | 6.35B | 4.72B | 3.99B |
| Total Liabilities | 12.65B | 12.44B | 9.93B | 10.58B | 9.72B | 8.19B |
| Stockholders Equity | 16.92B | 16.36B | 14.86B | 14.54B | 15.18B | 14.28B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 1.75B | 1.86B | -1.71B | -1.59B | -342.00M |
| Operating Cash Flow | 0 | 2.58B | 2.75B | 1.05B | 404.00M | 1.15B |
| Investing Cash Flow | 0 | -1.84B | -1.19B | -2.67B | -2.00B | -1.52B |
| Financing Cash Flow | 0 | 1.33B | -1.03B | 1.48B | 563.00M | 543.00M |
Daito Chemix Corporation Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4366, the sentiment is Negative. The current price of 448.00 is below the 20-day moving average (MA) of 502.00, below the 50-day MA of 469.34, and above the 200-day MA of 442.67, indicating a neutral trend. The MACD of -1.87 indicates Positive momentum. The RSI at 41.52 is Neutral, neither overbought nor oversold. The STOCH value of 35.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4366.
Daito Chemix Corporation Peers Comparison
Overall Rating
JP:501377Outperform
JP:409369Neutral
JP:922751Neutral- JP:436648Neutral
JP:496044Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:5013 | 77Outperform | JPY 41.24B | 9.76 | ― | 4.03% | -9.00% | -15.37% |
| JP:4093 | 69Neutral | JPY 14.44B | 11.14 | ― | 3.39% | -0.22% | 4.42% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| JP:9227 | 51Neutral | JPY 10.20B | -13.15 | ― | ― | ― | ― |
| JP:4366 | 48Neutral | JPY 14.84B | 12.41 | ― | 1.79% | 10.12% | 43.23% |
| JP:4960 | 44Neutral | JPY 8.17B | 26.66 | ― | 1.01% | -5.34% | 113.57% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4366 | Daito Chemix Corporation | 448.00 | 189.38 | 73.22% | |
| JP:4093 | Toho Acetylene Co., Ltd. | 413.00 | 68.03 | 19.72% | |
| JP:4960 | Chemipro Kasei Kaisya,Ltd. | 497.00 | 136.71 | 37.94% | |
| JP:5013 | Yushiro Chemical Industry Co., Ltd. | 3030.00 | 986.70 | 48.29% | |
| JP:9227 | Microwave Chemical Co., Ltd. | 639.00 | -99.00 | -13.41% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 31, 2026